Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Net Income towards Common Stockholders (2016 - 2025)

Nephros (NEPH) has 16 years of Net Income towards Common Stockholders data on record, last reported at $337000.0 in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 84.15% year-over-year to $337000.0; the TTM value through Sep 2025 reached $1.5 million, up 261.82%, while the annual FY2024 figure was $74000.0, 104.7% up from the prior year.
  • Net Income towards Common Stockholders reached $337000.0 in Q3 2025 per NEPH's latest filing, up from $246000.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $579000.0 in Q1 2025 and bottomed at -$3.2 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$622473.7, with a median of -$433000.0 recorded in 2023.
  • Peak YoY movement for Net Income towards Common Stockholders: tumbled 240.6% in 2022, then surged 428.98% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.1 million in 2021, then grew by 16.77% to -$918000.0 in 2022, then rose by 28.76% to -$654000.0 in 2023, then skyrocketed by 155.66% to $364000.0 in 2024, then fell by 7.42% to $337000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $337000.0 in Q3 2025, $246000.0 in Q2 2025, and $579000.0 in Q1 2025.